Outset Medical, Inc. (OM) — Analyst outlook / Analyst consensus target is. Based on 11 analyst ratings, the consensus is bullish — 7 Buy, 3 Hold, 1 Sell.
The consensus price target is $10.00 (low: $7.00, high: $15.00), representing an upside of 129.9% from the current price $4.35.
Analysts estimate Earnings Per Share (EPS) of $-27.88 and revenue of $0.11B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-2.46 vs est $-27.88 (beat +91.2%). 2025: actual $-5.37 vs est $-4.45 (missed -20.6%). Analyst accuracy: 0%.
OM Stock — 12-Month Price Forecast
$10.00
▲ +129.89% Upside
Average Price Target
Based on 11 Wall Street analysts offering 12-month price targets for Outset Medical, Inc., the average price target is $10.00, with a high forecast of $15.00, and a low forecast of $7.00.
The average price target represents a +129.89% change from the last price of $4.35.
Highest Price Target
$15.00
Average Price Target
$10.00
Lowest Price Target
$7.00
OM Analyst Ratings
Buy
Based on 11 analysts giving stock ratings to Outset Medical, Inc. in the past 3 months
EPS Estimates — OM
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$2.46
vs Est –$27.88
▲ 1,033.3% off
2025
Actual –$5.37
vs Est –$4.45
▼ 17.1% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — OM
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.114B
vs Est $0.113B
▲ 1.0% off
2025
Actual $0.119B
vs Est $0.117B
▲ 1.9% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
